Key Events This Week
27 Jul: Intraday high surge to Rs.2,638.95 (+7.48%)
28 Jul: Upgrade to Buy rating by MarketsMOJO
31 Jul: Week closes at Rs.2,514.70 (+2.03% weekly)
When is the next results date for Caplin Point Laboratories Ltd?
2026-07-30 23:17:06The next results date for Caplin Point Laboratories Ltd is scheduled for 12 August 2026....
Read full news article
Caplin Point Laboratories Ltd Upgraded to Buy on Strong Technical and Financial Performance
2026-07-28 08:40:16Caplin Point Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 27 Jul 2026, highlights the company’s robust quarterly performance, bullish technical signals, and sustained shareholder returns, positioning it favourably within the Pharmaceuticals & Biotechnology sector.
Read full news article
Caplin Point Laboratories Ltd Surges 7.48% to Day's High of Rs 2638.95 — Outperforms Sector by 5.42 Percentage Points
2026-07-27 14:47:32The Sensex advanced 1.03% on 27 Jul 2026, yet Caplin Point Laboratories Ltd outpaced the broader market with a robust 7.48% gain, reaching an intraday high of Rs 2638.95. This 5.42-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news articleCaplin Point Laboratories Declines 5.71%: Mixed Technical Signals Shape Weekly Performance
2026-07-26 09:01:54
Key Events This Week
20 Jul: Stock opens strong at Rs.2,647.75 (+1.29%) despite flat Sensex
22 Jul: Mojo Grade downgraded to Hold amid mixed technical and valuation signals
23 Jul: Technical momentum shifts to bullish despite 4.84% price drop
24 Jul: Week closes at Rs.2,464.65, down 0.90% on the day

Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicators
2026-07-23 08:02:36Caplin Point Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend despite a recent decline in price. The stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish cues from the monthly RSI and KST. This article analyses these technical parameters in detail, placing the stock’s performance in context with broader market movements and its historical returns.
Read full news article
Caplin Point Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals
2026-07-22 08:22:42Caplin Point Laboratories Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 21 July 2026. This adjustment reflects a nuanced reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite strong financial performance and consistent returns, evolving technical indicators and valuation concerns have tempered the outlook, prompting a more cautious stance among investors.
Read full news article
Caplin Point Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals
2026-07-22 08:01:52Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment.
Read full news articleCaplin Point Laboratories Limited - Press Release
03-Dec-2019 | Source : NSECaplin Point Laboratories Limited has informed the Exchange regarding a press release dated December 03, 2019, titled "CAPLIN STERILES GETS USFDA APPROVAL FOR SODIUM NITROPRUSSIDE INJECTION".
Caplin Point Laboratories Limited - Updates
22-Nov-2019 | Source : NSECaplin Point Laboratories Limited has informed the Exchange regarding 'Notice of Postal Ballot'.
Caplin Point Laboratories Limited - Reappointment
31-Oct-2019 | Source : NSECaplin Point Laboratories Limited has informed the Exchange regarding Reappointment of Director of the company.
Corporate Actions
12 Aug 2026
Caplin Point Laboratories Ltd has declared 200% dividend, ex-date: 29 May 26
Caplin Point Laboratories Ltd has announced 2:10 stock split, ex-date: 19 Oct 16
No Bonus history available
No Rights history available







